Company Ended First Quarter with $217 Million in Cash and Marketable Securities and No Debt Company Provides COVID-19 Business UpdateLYNNWOOD, Wash., […]
REDWOOD CITY, Calif., June 04, 2020 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting […]
BRIDGEWATER, N.J., June 04, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (“Menlo”) (Nasdaq: MNLO), a specialty pharmaceutical company focused on […]